Publication Date
| In 2024 | 0 |
| Since 2023 | 0 |
| Since 2020 (last 5 years) | 0 |
| Since 2015 (last 10 years) | 0 |
| Since 2005 (last 20 years) | 6 |
Descriptor
| Attention Deficit Disorders | 6 |
| Drug Therapy | 6 |
| Hyperactivity | 5 |
| Symptoms (Individual… | 4 |
| Children | 3 |
| Rating Scales | 3 |
| Diagnostic Tests | 2 |
| Measures (Individuals) | 2 |
| Outcomes of Treatment | 2 |
| Parent Attitudes | 2 |
| Severity (of Disability) | 2 |
| More ▼ | |
Source
| Child Psychiatry and Human… | 6 |
Author
| Amini, Homayoun | 1 |
| Butterbaugh, Grant J. | 1 |
| Chen, Mandy | 1 |
| Davari-Ashtiani, Rozita | 1 |
| Han, Changsu | 1 |
| Joe, Sook-Haeng | 1 |
| Johnston, Charlotte | 1 |
| Jung, In-Kwa | 1 |
| Kim, Seung-Hyun | 1 |
| Ko, Young-Hoon | 1 |
| Layman, Ann K. | 1 |
| More ▼ | |
Publication Type
| Journal Articles | 6 |
| Reports - Research | 6 |
Education Level
Audience
Location
| Venezuela | 1 |
Laws, Policies, & Programs
Assessments and Surveys
| Diagnostic Interview Schedule… | 1 |
What Works Clearinghouse Rating
Peer reviewed
Direct linkDavari-Ashtiani, Rozita; Shahrbabaki, Mahin Eslami; Razjouyan, Katayoon; Amini, Homayoun; Mazhabdar, Homa – Child Psychiatry and Human Development, 2010
The efficacy and side effects of buspirone compared with methylphenidate (MPH) in the treatment of children with attention-deficit/hyperactivity disorder (ADHD). A total of 34 children with ADHD as defined by DSM-IV-TR were randomized to buspirone or methylphenidate dosed on weight-adjusted basis at buspirone (0.5 mg/kg/day) and methylphenidate…
Descriptors: Attention Deficit Hyperactivity Disorder, Attention Deficit Disorders, Rating Scales, Drug Therapy
Manor, Iris; Meidad, Sheera; Zalsman, Gil; Zemishlany, Zvi; Tyano, Sam; Weizman, Abraham – Child Psychiatry and Human Development, 2008
Subjective improvement-assessment in attention deficit/hyperactivity disorder (ADHD), following a single dose of methylphenidate (MPH) was compared to performance on the Test-of-Variables-of-Attention (TOVA). Self-perception was assessed with the clinical-global-impression-of-change (CGI-C). Participants included 165 ADHD subjects (M:F ratio…
Descriptors: Hyperactivity, Attention Deficit Disorders, Drug Therapy, Metacognition
Lee, Moon-Soo; Yang, Jae-Won; Ko, Young-Hoon; Han, Changsu; Kim, Seung-Hyun; Lee, Min-Soo; Joe, Sook-Haeng; Jung, In-Kwa – Child Psychiatry and Human Development, 2008
We evaluated plasma levels of DHEA-S and cortisol before and after treating ADHD patients with one of two medications: methylphenidate (n = 12) or bupropion (n = 10). Boys with ADHD (combined type) were evaluated with the Korean ADHD rating scale (K-ARS) and the computerized ADHD diagnostic system (ADS). All assessments were measured at baseline…
Descriptors: Hyperactivity, Attention Deficit Disorders, Rating Scales, Patients
Montiel, Cecilia; Pena, Joaquin A.; Montiel-Barbero, Isabel; Polanczyk, Guilherme – Child Psychiatry and Human Development, 2008
A total of 1,535 4-12 year-old children were screened with the Conners' rating scales, followed by diagnostic confirmation by the diagnostic interview schedule for children-IV-parent version. The prevalence of ADHD was estimated to be 10.03%, and only 3.9% of children had received medication for the treatment of ADHD symptoms. Prevalence rates and…
Descriptors: Public Health, Hyperactivity, Attention Deficit Disorders, Rating Scales
Quintana, Humberto; Butterbaugh, Grant J.; Purnell, William; Layman, Ann K. – Child Psychiatry and Human Development, 2007
Children with attention-deficit/hyperactivity disorder (ADHD) are at increased risk for developing comorbid non-bipolar mood disorders. Fluoxetine monotherapy is an established treatment for pediatric mood disorders; however its efficacy in ADHD and comorbid mood disorder is unknown. Therefore, we evaluated 30 children who met DSM-IV criteria for…
Descriptors: Hyperactivity, Depression (Psychology), Drug Therapy, Attention Deficit Disorders
Chen, Mandy; Seipp, Carla M.; Johnston, Charlotte – Child Psychiatry and Human Development, 2008
This study examined parent and child gender effects on parents' attributions and beliefs in regards to child symptoms of attention-deficit/hyperactivity disorder (ADHD). Participants included mothers and fathers of 19 girls and 17 boys with ADHD. Groups of boys and girls, aged 5-13 years, were equated on age and medication status, as well as ADHD…
Descriptors: Mothers, Hyperactivity, Attention Deficit Disorders, Child Behavior
